Primarily lower sales as well as a steep fall in gross margins led to the weak financial performance of the company during ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

NATCO Pharma stock has declined 34% over six days due to disappointing Q3 FY25 results, including a 37.4% revenue drop and a ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

Q2 2025 Earnings Call Transcript February 13, 2025 Operator: Welcome to the S&W Seed Company Second Quarter Fiscal Year 2025 ...

Western Forest Products Inc. ( OTCPK:WFSTF) Q4 2024 Earnings Conference Call February 14, 2025 12:00 PM ET Steven Hofer - President and CEO Glenn Nontell - CFO Bruce Alexander - SVP of Sales, ...

Conservatives who have spent decades promoting deep cuts to government are giving mixed reviews to the Department of ...

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and ...

French luxury group Hermes reported fourth-quarter results well above analyst expectations on Friday, showing robust appetite ...

This milestone reflects the company’s focus on innovation, aggressive network expansion, cost optimisation, and ...

On Feb. 13, a petition from Steven Wilson went before the Yarmouth Zoning Board of Appeals but didn’t make it very far.

AQN stock continues to wrestle with high debt levels and an elevated dividend payout ratio in 2025. This TSX dividend stock is a better buy right now.